Bioptik Technology Incorporation (TPEX:4161)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.85
0.00 (0.00%)
May 29, 2025, 1:02 PM CST
-5.66%
Market Cap 1.63B
Revenue (ttm) 841.24M
Net Income (ttm) 90.29M
Shares Out 52.94M
EPS (ttm) 1.73
PE Ratio 17.84
Forward PE n/a
Dividend 0.30 (0.97%)
Ex-Dividend Date n/a
Volume 48,130
Average Volume 69,662
Open 31.00
Previous Close 30.85
Day's Range 30.45 - 31.20
52-Week Range 27.50 - 38.50
Beta 0.27
RSI 36.00
Earnings Date Aug 11, 2025

About TPEX:4161

Bioptik Technology Incorporation engages in the production and sale of medical devices and reagents worldwide. It offers EasyMate blood glucose monitoring systems; blood glucose/cholesterol/uric acid monitoring systems and its strips; and hyaluronic acid skin care products. The company also provides skin care products and dietary supplements, as well as biodiesel products. Bioptik Technology Incorporation was founded in 1999 and is based in Zhunan, Taiwan. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1999
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4161
Full Company Profile

Financial Performance

In 2024, TPEX:4161's revenue was 865.34 million, an increase of 4.45% compared to the previous year's 828.50 million. Earnings were 93.57 million, an increase of 9.17%.

Financial Statements

News

There is no news available yet.